Resistell in a CHF 8.5M series B round backed by EIC Fund, TRUMPF Venture, OCCIDENT, Zürcher Kantonalbank, Launchpad. Biotech Health services Manufacturing Pharma Investments 09 December 2022 Share:
Round value (USD): 9.17m Round investors: EIC Fund OCCIDENT Trumpf Venture Zürcher Kantonalbank Launchpad Company: Resistell Industry: Biotech Health services Manufacturing Pharma
Biolytica raised a CHF 5.25 seed round from the Maximon Longevity Co-Investment Fund.. AI (big data) Biotech Competitive Intelligence Health services Software Services Investments 30 April 2023
Cellvie closes $5.5M of additional funding led by Taiho Ventures, with participation from earlier investors Kizoo Technology Capital Health services Manufacturing Pharma Investments 04 February 2023
Xsensio raised CHF5.5M with Privilège Ventures, Mayo Clinic Ventures and European Innovation Council Health services Manufacturing Software Services Wearable Investments 03 December 2022
Aspivix closes $5M Series A+ Funding Round led by HEMEX, joined by 4FOx ventures, Zürcher Kantonalbank and LaunchPad APAC. Health services Manufacturing Investments 11 November 2022
Navignostics to raise CHF7.5M from swiss investors Biotech Health services Pharma Software Services Investments 04 November 2022